Mirum Pharmaceuticals, Inc. - common stock (MIRM) earnings
MIRM earnings moved a median of +0.42% by the close. Quarterly and annual MIRM reports and results, each read against the price at its own news timestamp. Back to the MIRM overview →
31 measured MIRM earnings events.
Where these MIRM earnings landedvs 31 measured MIRM earnings reactions
| Middle 50% of MIRM earnings reactions | -2.10% to +2.56% |
|---|---|
| Median reaction (to close) | +0.42% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 MIRM earnings events with a measured close landed between -2.10% and +2.56%; 61% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Mirum Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +1.29% | +4.28% | |
| Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | +1.29% | +4.28% | |
| Mirum Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026 | Press release | +0.04% | +4.21% | |
| Form 10-Q Mirum Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -4.51% | -6.50% | |
| Mirum Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | -4.51% | -6.50% | |
| Mirum Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 6, 2026 | Press release | +0.13% | +1.83% | |
| Form 10-K Mirum Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -0.55% | -4.50% | |
| Form 10-Q Mirum Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -3.31% | -4.55% | |
| Mirum Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | -3.31% | -4.55% | |
| Mirum Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025 | Press release | -1.45% | +0.30% | |
| Form 10-Q Mirum Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +7.73% | +8.27% | |
| Mirum Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | +7.73% | +8.27% | |
| Mirum Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 6, 2025 | Press release | +1.39% | +1.39% | |
| Form 10-Q Mirum Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -1.44% | +5.21% | |
| Mirum Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | -1.44% | +5.21% | |
| Mirum Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 | Press release | +0.02% | +2.52% | |
| Form 10-K Mirum Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -3.77% | -2.18% | |
| Form 10-Q Mirum Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +3.79% | -3.91% | |
| Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | +3.79% | -3.91% | |
| Mirum Pharmaceuticals to Announce Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024 | Press release | -2.22% | +2.60% | |
| Form 10-Q Mirum Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -0.41% | +2.34% | |
| Mirum Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | -0.41% | +2.34% | |
| Mirum Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 7, 2024 | Press release | -0.22% | -0.74% | |
| Form 10-Q Mirum Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -2.26% | +0.58% | |
| Mirum Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | -2.26% | +0.58% | |
| Mirum Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024 | Press release | +0.00% | -0.85% | |
| Form 10-K Mirum Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -0.53% | -1.96% | |
| Form NT 10-K Mirum Pharmaceuticals, For: Dec 31 | SEC filing · Form NT | -1.33% | +0.42% | |
| Form 10-Q Mirum Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -0.72% | +0.33% | |
| Mirum Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | -0.72% | +0.33% | |
| Mirum Pharmaceuticals to Announce Third Quarter 2023 Financial Results and Host Conference Call on November 2, 2023 | Press release | -1.19% | -2.02% |
Keep exploring
More MIRM: analyst actions → · SEC filings → · MIRM overview →